Abstract: This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamid e, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
Type:
Grant
Filed:
February 5, 1992
Date of Patent:
October 19, 1993
Assignee:
Eli Lilly and Company
Inventors:
George B. Boder, William J. Ehlhardt, Gerald B. Grindey, John E. Toth, John F. Worzalla, John L. Zimmermann